Open Accessβ-Blocker Use in Long-term Dialysis Patients
Author(s) -
Kevin C. Abbott,
F. Trespalacios,
Lawrence Y. Agodoa,
Allen J. Taylor,
George L. Bakris
Publication year - 2004
Publication title -
archives of internal medicine
Language(s) - English
Resource type - Journals
eISSN - 1538-3679
pISSN - 0003-9926
DOI - 10.1001/archinte.164.22.2465
Subject(s) - medicine , hazard ratio , dialysis , proportional hazards model , heart failure , confidence interval , population , retrospective cohort study , beta blocker , cardiology , environmental health
beta-Blockers have been shown to be beneficial in the treatment and prevention of heart failure (HF) in the general population, but they have not been assessed for their association with nonfatal HF in a nationally representative population of long-term dialysis patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom